Ganesh V. Kaundinya

2012

In 2012, Ganesh V. Kaundinya earned a total compensation of $892.2K as Chief Scientific Officer and Senior Vice President, Research at Momenta Pharmaceuticals, a 41% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$98,274
Option Awards$245,539
Salary$374,379
Stock Awards$161,703
Other$12,324
Total$892,219

Kaundinya received $374.4K in salary, accounting for 42% of the total pay in 2012.

Kaundinya also received $98.3K in non-equity incentive plan, $245.5K in option awards, $161.7K in stock awards and $12.3K in other compensation.

Rankings

In 2012, Ganesh V. Kaundinya's compensation ranked 6,591st out of 11,487 executives tracked by ExecPay. In other words, Kaundinya earned more than 42.6% of executives.

ClassificationRankingPercentile
All
6,591
out of 11,487
43rd
Division
Manufacturing
2,367
out of 4,253
44th
Major group
Chemicals And Allied Products
597
out of 1,198
50th
Industry group
Drugs
409
out of 920
56th
Industry
Biological Products, Except Diagnostic Substances
66
out of 160
59th
Source: SEC filing on April 24, 2015.

Kaundinya's colleagues

We found four more compensation records of executives who worked with Ganesh V. Kaundinya at Momenta Pharmaceuticals in 2012.

2012

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2012

Bruce Leicher

Momenta Pharmaceuticals

General Counsel

2012

James Roach

Momenta Pharmaceuticals

Chief Medical Officer

2012

Richard Shea

Momenta Pharmaceuticals

Chief Financial Officer

You may also like